Purchase Order HT001423P0234
Award Date
9/19/23
Potential Completion Date
9/29/24
Potential Value
$55K
Federal Agency
Defense Health Agency
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
Qiagen, LLC was awarded a $17,393.80 firm fixed price delivery order by the Defense Health Agency to provide TEST KITS. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. No set-aside designation was applied to this award. Performance will take place in Germantown, Maryland through September 30, 2024. Qiagen holds several indefinite delivery contracts with federal agencies including...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....
This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Qiagen, LLC, a division of the international medical diagnostics company Qiagen N.V. The contract, valued at $80,457.60, is for the supply of various QIAGEN laboratory supplies including DNA/RNA extraction kits, PCR reagents, and related equipment. This contract was awarded under an unrestricted solicitation and did not have a set-aside designation. Qiagen, as a manufacturer of these specialized...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
This is a $24,716 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract is for the provision of services related to Qiagen's products and technologies, which the company has supplied to various federal agencies in the past, including the Department of Health and Human Services, Department of Defense, and Department of Justice. Qiagen holds several...